Sarà rimborsata dal Ssn la prima terapia di editing genetico per la β-talassemia e l’anemia falciforme Notizia in evidenza

Italian Medicines Agency published this content on September 18, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 18, 2025 at 13:24 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]